Materialise (NASDAQ:MTLS – Get Free Report) and Riskified (NYSE:RSKD – Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.
Insider & Institutional Ownership
19.3% of Materialise shares are owned by institutional investors. Comparatively, 59.0% of Riskified shares are owned by institutional investors. 1.2% of Materialise shares are owned by insiders. Comparatively, 17.4% of Riskified shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk and Volatility
Materialise has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, Riskified has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Materialise | 0 | 2 | 1 | 0 | 2.33 |
| Riskified | 1 | 3 | 3 | 0 | 2.29 |
Materialise presently has a consensus target price of $10.00, suggesting a potential upside of 56.01%. Riskified has a consensus target price of $6.00, suggesting a potential upside of 15.19%. Given Materialise’s stronger consensus rating and higher possible upside, equities analysts plainly believe Materialise is more favorable than Riskified.
Earnings and Valuation
This table compares Materialise and Riskified”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Materialise | $302.73 million | 1.25 | $8.73 million | $0.20 | 32.05 |
| Riskified | $344.64 million | 2.24 | -$27.57 million | ($0.11) | -47.35 |
Materialise has higher earnings, but lower revenue than Riskified. Riskified is trading at a lower price-to-earnings ratio than Materialise, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Materialise and Riskified’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Materialise | 3.77% | 4.05% | 2.47% |
| Riskified | -5.17% | -3.91% | -2.89% |
Summary
Materialise beats Riskified on 8 of the 14 factors compared between the two stocks.
About Materialise
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
About Riskified
Riskified Ltd., together with its subsidiaries, develops and offers an e-commerce risk management platform that allows online merchants to create trusted relationships with consumers in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and the Americas. It offers Chargeback Guarantee that ensures the legitimacy of merchants' online orders; Policy Protect, a machine learning solution designed to detect and prevent refund and returns policy abuse in real-time; Account Secure, a solution that cross-checks every login attempt; Dispute Resolve, which is used to compile submissions for fraud and non-fraud related chargeback issues; and PSD2 Optimize that helps merchants avoid bank authorization failures and abandoned shopping carts. The company serves direct-to-consumer brands, online-only retailers, omnichannel retailers, online marketplaces, and e-commerce service providers in various industries, such as payments, money transfer and crypto, tickets and travel, electronics, home, and fashion and luxury goods. Riskified Ltd. was incorporated in 2012 and is headquartered in Tel Aviv, Israel.
Receive News & Ratings for Materialise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Materialise and related companies with MarketBeat.com's FREE daily email newsletter.
